| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |